Table of Content

Table of Contents

Global Submucosal Injections Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Submucosal Injections Market by Value
2.2.1 Global Submucosal Injections Revenue by Type
2.2.2 Global Submucosal Injections Market by Value (%)
2.3 Global Submucosal Injections Market by Production
2.3.1 Global Submucosal Injections Production by Type
2.3.2 Global Submucosal Injections Market by Production (%)

3. The Major Driver of Submucosal Injections Industry
3.1 Historical & Forecast Global Submucosal Injections Demand
3.2 Largest Application for Submucosal Injections (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Submucosal Injections Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Submucosal Injections Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Submucosal Injections Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Submucosal Injections Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Submucosal Injections Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Submucosal Injections Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Submucosal Injections Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Submucosal Injections Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Submucosal Injections Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Submucosal Injections Average Price Trend
12.1 Market Price for Each Type of Submucosal Injections in US (2018-2022)
12.2 Market Price for Each Type of Submucosal Injections in Europe (2018-2022)
12.3 Market Price for Each Type of Submucosal Injections in China (2018-2022)
12.4 Market Price for Each Type of Submucosal Injections in Japan (2018-2022)
12.5 Market Price for Each Type of Submucosal Injections in India (2018-2022)
12.6 Market Price for Each Type of Submucosal Injections in Korea (2018-2022)
12.7 Market Price for Each Type of Submucosal Injections in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Submucosal Injections Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Submucosal Injections

14. Submucosal Injections Competitive Landscape
14.1 Cosmo Pharmaceuticals NV
14.1.1 Cosmo Pharmaceuticals NV Company Profiles
14.1.2 Cosmo Pharmaceuticals NV Product Introduction
14.1.3 Cosmo Pharmaceuticals NV Submucosal Injections Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 GLR Innovations
14.2.1 GLR Innovations Company Profiles
14.2.2 GLR Innovations Product Introduction
14.2.3 GLR Innovations Submucosal Injections Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Toronto Research Chemicals
14.3.1 Toronto Research Chemicals Company Profiles
14.3.2 Toronto Research Chemicals Product Introduction
14.3.3 Toronto Research Chemicals Submucosal Injections Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Carbosynth Ltd
14.4.1 Carbosynth Ltd Company Profiles
14.4.2 Carbosynth Ltd Product Introduction
14.4.3 Carbosynth Ltd Submucosal Injections Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Frontier Specialty Chemicals
14.5.1 Frontier Specialty Chemicals Company Profiles
14.5.2 Frontier Specialty Chemicals Product Introduction
14.5.3 Frontier Specialty Chemicals Submucosal Injections Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Thermo Fisher Scientific
14.6.1 Thermo Fisher Scientific Company Profiles
14.6.2 Thermo Fisher Scientific Product Introduction
14.6.3 Thermo Fisher Scientific Submucosal Injections Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Merck
14.7.1 Merck Company Profiles
14.7.2 Merck Product Introduction
14.7.3 Merck Submucosal Injections Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Target Molecule Corp.
14.8.1 Target Molecule Corp. Company Profiles
14.8.2 Target Molecule Corp. Product Introduction
14.8.3 Target Molecule Corp. Submucosal Injections Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 3B Scientific
14.9.1 3B Scientific Company Profiles
14.9.2 3B Scientific Product Introduction
14.9.3 3B Scientific Submucosal Injections Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Advance Scientific and Chemical
14.10.1 Advance Scientific and Chemical Company Profiles
14.10.2 Advance Scientific and Chemical Product Introduction
14.10.3 Advance Scientific and Chemical Submucosal Injections Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Sidley Chemical
14.12 MedChemExpress
14.13 Alfa Chemistry
14.14 Scientific Polymer Products, Inc.
14.15 AK Scientific Inc.
14.16 CarboMer, Inc.
14.17 Spectrum Chemical Mfg. Corp.
14.18 Chemos GmbH and Co. KG
14.19 Kraeber and Co GmbH
14.20 Tokyo Chemical Industry Co.,Ltd.
14.21 Dalian Meilun Biotechnology Co., Ltd
14.22 Shanghai Meiruier Chemical Technology Co., Ltd
14.23 J&K Scientific
14.24 Shanghai Yuanye Bio-Technology Co., Ltd
14.25 Guangdong Wengjiang Chemical Reagent Co., Ltd
14.26 Nanjing Luomaimei Biotechnology Co., Ltd
14.27 Beijing Wokai Biotechnology Co., Ltd
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Submucosal Injections Industry (Volume)
Figure 2. Submucosal Injections Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Submucosal Injections Revenue in 2022
Figure 5. US Submucosal Injections Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Submucosal Injections Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Submucosal Injections Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Submucosal Injections Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Submucosal Injections Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Submucosal Injections Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Submucosal Injections Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Submucosal Injections Revenue, by Type (Million USD) (2018-2028)
Table 4. Submucosal Injections Production, by Type (K Unit) (2018-2028)
Table 5. Submucosal Injections Demand (K Unit) by Application (2018-2028)
Table 6. Submucosal Injections Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Submucosal Injections Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Submucosal Injections Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Submucosal Injections in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Submucosal Injections in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Submucosal Injections in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Submucosal Injections in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Submucosal Injections in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Submucosal Injections in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Submucosal Injections in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Cosmo Pharmaceuticals NV Profiles
Table 61. Cosmo Pharmaceuticals NV Submucosal Injections Product Introduction
Table 62. Cosmo Pharmaceuticals NV Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Cosmo Pharmaceuticals NV Strategic initiatives
Table 64. GLR Innovations Profiles
Table 65. GLR Innovations Submucosal Injections Product Introduction
Table 66. GLR Innovations Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. GLR Innovations Strategic initiatives
Table 68. Toronto Research Chemicals Profiles
Table 69. Toronto Research Chemicals Submucosal Injections Product Introduction
Table 70. Toronto Research Chemicals Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Toronto Research Chemicals Strategic initiatives
Table 72. Carbosynth Ltd Profiles
Table 73. Carbosynth Ltd Submucosal Injections Product Introduction
Table 74. Carbosynth Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Carbosynth Ltd Strategic initiatives
Table 76. Frontier Specialty Chemicals Profiles
Table 77. Frontier Specialty Chemicals Submucosal Injections Product Introduction
Table 78. Frontier Specialty Chemicals Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Frontier Specialty Chemicals Strategic initiatives
Table 80. Thermo Fisher Scientific Profiles
Table 81. Thermo Fisher Scientific Submucosal Injections Product Introduction
Table 82. Thermo Fisher Scientific Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Thermo Fisher Scientific Strategic initiatives
Table 84. Merck Profiles
Table 85. Merck Submucosal Injections Product Introduction
Table 86. Merck Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Merck Strategic initiatives
Table 88. Target Molecule Corp. Profiles
Table 89. Target Molecule Corp. Submucosal Injections Product Introduction
Table 90. Target Molecule Corp. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Target Molecule Corp. Strategic initiatives
Table 92. 3B Scientific Profiles
Table 93. 3B Scientific Submucosal Injections Product Introduction
Table 94. 3B Scientific Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. 3B Scientific Strategic initiatives
Table 97. Advance Scientific and Chemical Profiles
Table 98. Advance Scientific and Chemical Submucosal Injections Product Introduction
Table 99. Advance Scientific and Chemical Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Advance Scientific and Chemical Strategic initiatives
Table 101. Sidley Chemical Profiles
Table 102. Sidley Chemical Submucosal Injections Product Introduction
Table 103. Sidley Chemical Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Sidley Chemical Strategic initiatives
Table 105. MedChemExpress Profiles
Table 106. MedChemExpress Submucosal Injections Product Introduction
Table 107. MedChemExpress Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. MedChemExpress Strategic initiatives
Table 109. Alfa Chemistry Profiles
Table 110. Alfa Chemistry Submucosal Injections Product Introduction
Table 111. Alfa Chemistry Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Alfa Chemistry Strategic initiatives
Table 113. Scientific Polymer Products, Inc. Profiles
Table 114. Scientific Polymer Products, Inc. Submucosal Injections Product Introduction
Table 115. Scientific Polymer Products, Inc. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Scientific Polymer Products, Inc. Strategic initiatives
Table 117. AK Scientific Inc. Profiles
Table 118. AK Scientific Inc. Submucosal Injections Product Introduction
Table 119. AK Scientific Inc. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. AK Scientific Inc. Strategic initiatives
Table 121. CarboMer, Inc. Profiles
Table 122. CarboMer, Inc. Submucosal Injections Product Introduction
Table 123. CarboMer, Inc. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. CarboMer, Inc. Strategic initiatives
Table 125. Spectrum Chemical Mfg. Corp. Profiles
Table 126. Spectrum Chemical Mfg. Corp. Submucosal Injections Product Introduction
Table 127. Spectrum Chemical Mfg. Corp. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Spectrum Chemical Mfg. Corp. Strategic initiatives
Table 129. Chemos GmbH and Co. KG Profiles
Table 130. Chemos GmbH and Co. KG Submucosal Injections Product Introduction
Table 131. Chemos GmbH and Co. KG Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 132. Chemos GmbH and Co. KG Strategic initiatives
Table 133. Kraeber and Co GmbH Profiles
Table 134. Kraeber and Co GmbH Submucosal Injections Product Introduction
Table 135. Kraeber and Co GmbH Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 136. Kraeber and Co GmbH Strategic initiatives
Table 137. Tokyo Chemical Industry Co.,Ltd. Profiles
Table 138. Tokyo Chemical Industry Co.,Ltd. Submucosal Injections Product Introduction
Table 139. Tokyo Chemical Industry Co.,Ltd. Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 140. Tokyo Chemical Industry Co.,Ltd. Strategic initiatives
Table 141. Dalian Meilun Biotechnology Co., Ltd Profiles
Table 142. Dalian Meilun Biotechnology Co., Ltd Submucosal Injections Product Introduction
Table 143. Dalian Meilun Biotechnology Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 144. Dalian Meilun Biotechnology Co., Ltd Strategic initiatives
Table 145. Shanghai Meiruier Chemical Technology Co., Ltd Profiles
Table 146. Shanghai Meiruier Chemical Technology Co., Ltd Submucosal Injections Product Introduction
Table 147. Shanghai Meiruier Chemical Technology Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 148. Shanghai Meiruier Chemical Technology Co., Ltd Strategic initiatives
Table 149. J&K Scientific Profiles
Table 150. J&K Scientific Submucosal Injections Product Introduction
Table 151. J&K Scientific Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 152. J&K Scientific Strategic initiatives
Table 153. Shanghai Yuanye Bio-Technology Co., Ltd Profiles
Table 154. Shanghai Yuanye Bio-Technology Co., Ltd Submucosal Injections Product Introduction
Table 155. Shanghai Yuanye Bio-Technology Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 156. Shanghai Yuanye Bio-Technology Co., Ltd Strategic initiatives
Table 157. Guangdong Wengjiang Chemical Reagent Co., Ltd Profiles
Table 158. Guangdong Wengjiang Chemical Reagent Co., Ltd Submucosal Injections Product Introduction
Table 159. Guangdong Wengjiang Chemical Reagent Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 160. Guangdong Wengjiang Chemical Reagent Co., Ltd Strategic initiatives
Table 161. Nanjing Luomaimei Biotechnology Co., Ltd Profiles
Table 162. Nanjing Luomaimei Biotechnology Co., Ltd Submucosal Injections Product Introduction
Table 163. Nanjing Luomaimei Biotechnology Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 164. Nanjing Luomaimei Biotechnology Co., Ltd Strategic initiatives
Table 165. Beijing Wokai Biotechnology Co., Ltd Profiles
Table 166. Beijing Wokai Biotechnology Co., Ltd Submucosal Injections Product Introduction
Table 167. Beijing Wokai Biotechnology Co., Ltd Submucosal Injections Production (Unit), Revenue (Million USD) (2018-2022)
Table 168. Beijing Wokai Biotechnology Co., Ltd Strategic initiatives